Secured $150M financing and prepared Peloton Therapeutics for IPO — laying groundwork for Merck & Co. acquisition.
Led deal-critical Hepatitis C project at Arrow Therapeutics prior to acquisition by AstraZeneca.
Led the identification and development of OlysioTM for chronic hepatitis C virus.
Built value for two top-tier biotech companies via pivotal drug development strategies.
Spearheaded the GSK erbB2 Oncology Project Team that discovered Tykerb™ for metastatic breast cancer.